The equity portion of the abrdn World Healthcare Fund fell (gross) but outperformed its custom benchmark over Q4 2024. Click ...
StockStory.org on MSN5d
Humana (HUM): Buy, Sell, or Hold Post Q4 Earnings?Humana’s shares (currently trading at $268.69) have posted a disappointing 15.2% loss while the S&P 500 was down 1.4%. This ...
We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...
Disappointing performance since the ... and the newer addition Humana offset these gains. The team has taken profits in Meta as its stock gained more than 500% from its late 2022 lows, but it ...
Shares of Humana Inc. HUM shed 1.82% to $264.58 Friday, on what proved to be an all-around poor trading session for the stock ...
Investors in Humana Inc. (Symbol: HUM) saw new options become available today, for the May 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the HUM options ...
The institutional investor owned 58,663 shares of the insurance provider’s stock after selling 31,247 shares during the period. Korea Investment CORP’s holdings in Humana were worth $ ...
Humana has announced that it has issued an additional $250 million of senior unsecured notes under that offering, bringing the total to $1.5 billion. The outlook of the Credit Rating (rating ...
For the first time in 15 years, employment across the major health insurance companies fell last year, according to a Modern Healthcare analysis.
2don MSN
The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...
The stock has a consensus rating of “Hold” from the 18 analysts covering it, and the mean price target of $41.61 suggests a slight 5.1% premium to its current levels. On the date of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results